Latest Strategy Changes News

Champion Iron Limited reported record quarterly sales and strong earnings in FY2025 Q4, while advancing its DRPF project on schedule and declaring its eighth consecutive dividend.

Champion Iron Limited reported a 5% increase in revenue to C$1.606 billion for the year ended March 31, 2025, while net profit fell sharply by 39% to C$142 million. The company declared an unfranked interim dividend of C$0.10 per share.

ikeGPS Group Limited (IKE) reported a robust FY25 with 19% revenue growth driven by subscription gains and improved margins, setting the stage for EBITDA break-even in FY26 H2 amid strong North American market demand.

ikeGPS Group Limited reported a robust 48% growth in annual subscription revenue exit run rate for FY25, alongside improved margins and a narrowed EBITDA loss. Despite a lucrative NZ$1 per share acquisition approach, the company declined the offer, confident in its growth trajectory.

ikeGPS Limited has posted a 19.2% increase in revenue for the year ending March 2025, reaching NZD 25.155 million, yet the company recorded a significant net loss of NZD 16.338 million with no dividend declared.

Asara Resources assures investors its Kada Gold Project permits remain intact despite Guinea’s recent revocation of over 120 exploration permits. Drilling has already commenced, signaling continued progress.

ASX has suspended trading of Magnum Mining’s MGUN securities following the abrupt cancellation of its entitlement offer, raising questions about the company’s capital strategy.

FAR Limited has been formally hit with a $6 million claim from Woodside Energy related to unrecoverable petroleum expenditures in Senegal, raising questions about potential financial exposure.

Talius Group Limited has secured shareholder approval to consolidate its shares on a 10-for-1 basis, aiming to better align its capital structure with industry peers. The move affects all ordinary shares and performance rights, effective June 4, 2025.

Avecho Biotechnology has received $1.66 million from the Australian Government’s R&D Tax Incentive, reinforcing its commitment to a pivotal Phase III trial for its CBD-based insomnia treatment and accelerating its commercial ambitions.

CAQ Holdings Limited has resumed trading on the ASX following the release of its annual report and an update on a new debt facility and company restructure.

CAQ Holdings Limited has successfully restructured its debt repayment schedule and secured a new RMB 6 million loan facility, positioning itself to support operational growth amid efforts to increase occupancy rates.